METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2Ξ±-PERK interaction and promoting PSMB5 translation
13 March 2026 at 08:00
Oncogene, Published online: 13 March 2026; doi:10.1038/s41388-026-03706-y
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2Ξ±-PERK interaction and promoting PSMB5 translation